Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children with Cerebral Palsy - A Randomized Controlled Trial.
- Conditions
- Cerebral PalsyBrain-Related Movement Disorder10028037
- Registration Number
- NL-OMON56709
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 66
- Children with cerebral palsy or a related non-progressive disorder between
the ages of 4 and 12.
- Gross Motor Function Classification System (GMFCS) level I - III.
- Parents and/or children have a treatment question related to either walking
ability and/or participation of their child.
- Participants that suffer from a progressive neurological disorder.
- Treatment with botulinum toxin and/or serial casting in lower extremities
planned during the study.
- Treatment with botulinum toxin in the 12 weeks prior to the study.
- Treatment with serial casting in the 3 weeks prior to the study.
- Children that underwent a selective dorsal rhizotomy in the 12 months before
participation in the study.
- Children that underwent orthopedic surgery on their lower extremities in the
12 months before participation in the study.
- Children that have already received MegaPower training in the last 4 months
before participation in the study
- Children for whom walking is not their preferred method of locomotion (yet).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method